2012-11-01
Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline
Publication
Publication
Critical Reviews in Oncology / Hematology , Volume 84 - Issue 2 p. 252- 260
Breast cancer is the most common malignancy amongst women in the developed world. For patients with hormone-sensitive breast cancer eligible for adjuvant hormonal therapy, it is important to know if the ovaries are (still) functional or not. Indeed, the choice for a specific adjuvant hormonal treatment depends on the menopausal status of an individual woman. The currently available measures to determine the menopausal status are conflicting. Until better measures become available, we propose a practical guideline enabling an optimal choice of adjuvant hormonal therapy for women with a hormone receptor positive breast cancer taking into account uncertainties about their menopausal status.
| Additional Metadata | |
|---|---|
| , , | |
| doi.org/10.1016/j.critrevonc.2012.06.005, hdl.handle.net/1765/73242 | |
| Critical Reviews in Oncology / Hematology | |
| Organisation | Department of Gynaecology & Obstetrics |
|
de Vos, F. Y. F. L., van Laarhoven, H., Laven, J., Themmen, A., Beex, L., Sweep, C. G. J., … Jager, A. (2012). Menopausal status and adjuvant hormonal therapy for breast cancer patients: A practical guideline. Critical Reviews in Oncology / Hematology (Vol. 84, pp. 252–260). doi:10.1016/j.critrevonc.2012.06.005 |
|
